Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors, Colorectal, and Breast Cancer

Multiple Cancer Types

An open-label, dose escalation and expansion clinical trial to evaluate the safety, tolerability, and PK of fruquintinib in patients with advanced solid tumors, metastatic colorectal cancer and metastatic breast cancer.
Colon, Miscellaneous, Phase I, Rectal
I
Eng, Cathy
NCT03251378
VICCGIP1965

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: